Free Trial

Fortrea (FTRE) Stock Forecast & Price Target

$26.00
+1.25 (+5.05%)
(As of 07/12/2024 ET)

Fortrea - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$32.30
24.23% Upside
High Forecast$44.00
Average Forecast$32.30
Low Forecast$27.00
TypeCurrent Forecast
7/14/23 to 7/13/24
1 Month Ago
6/14/23 to 6/13/24
3 Months Ago
4/15/23 to 4/14/24
1 Year Ago
7/14/22 to 7/14/23
Consensus Rating
Moderate Buy
Moderate Buy
Hold
N/A
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
5 Buy rating(s)
5 Buy rating(s)
4 Buy rating(s)
N/A
Hold
5 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
N/A
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
N/A
Consensus Price Target$32.30$32.30$37.29N/A
Forecasted Upside24.23% Upside13.67% Upside12.81% UpsideN/A
Get Fortrea Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter.

FTRE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

FTRE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fortrea Stock vs. The Competition

TypeFortreaMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.71
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside24.23% Upside994.26% Upside9.17% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/6/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$28.00+2.38%
5/29/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$27.00+7.14%
5/28/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$27.00+5.68%
5/23/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$36.00 ➝ $28.00+9.33%
5/14/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Coldwell
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/14/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$33.00 ➝ $27.00-6.12%
5/14/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$43.00 ➝ $31.00+10.28%
5/14/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$45.00 ➝ $36.00+28.07%
1/25/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$38.00 ➝ $35.00+11.08%
1/5/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Smock
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
1/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$44.00+32.13%
12/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$34.00 ➝ $40.00+30.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:05 PM ET.

FTRE Forecast - Frequently Asked Questions

What is Fortrea's forecast for 2024?

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Fortrea is $32.30, with a high forecast of $44.00 and a low forecast of $27.00.

Should I buy or sell Fortrea stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fortrea in the last year. There is currently 1 sell rating, 5 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" FTRE shares.

Does Fortrea's stock price have much upside?

According to analysts, Fortrea's stock has a predicted upside of 13.67% based on their 12-month stock forecasts.

Has Fortrea been upgraded by Wall Street analysts recently?

Over the previous 90 days, Fortrea's stock had 2 upgrades by analysts.

What analysts cover Fortrea?

Fortrea has been rated by research analysts at Baird R W, Bank of America, Deutsche Bank Aktiengesellschaft, Evercore ISI, Mizuho, Robert W. Baird, TD Cowen, and The Goldman Sachs Group in the past 90 days.

Do Wall Street analysts like Fortrea more than its competitors?

Analysts like Fortrea less than other "medical" companies. The consensus rating score for Fortrea is 2.50 while the average consensus rating score for "medical" companies is 2.71. Learn more on how FTRE compares to other companies.


This page (NASDAQ:FTRE) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners